(Q46477429)

English

The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase

scientific article published on 17 July 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Reza Khosravan

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

Michael J Kukulka

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

Jing-Tao Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

Nancy Joseph-Ridge

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

Laurent Vernillet

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

publication date

17 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

48

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

1014-1024

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

Epidemiology of gout and hyperuricemia. A long-term population study

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322035

21 January 2018

Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322035

21 January 2018

Incidence and risk factors for gout in white men.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322035

21 January 2018

Gout: can management be improved?

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322035

21 January 2018

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322035

21 January 2018

Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322035

21 January 2018

Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322035

21 January 2018

An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322035

21 January 2018

Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322035

21 January 2018

The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase

1 reference

https://api.crossref.org/works/10.1177%2F0091270008322035

21 January 2018

Identifiers

10.1177/0091270008322035

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18635756

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46477429&oldid=2143962673"